Andrew M.

Pioneer
DISC Type : DIS

Chief Medical Officer & Strategic Bioanalytical and Translational Research Officer at GLSA | Global Life Sciences Alliance

Greater Seattle Area, United States

Overview

Andrew M. is a senior leader with over 20 years of experience managing global pre-clinical and clinical programs in CRO and Pharma environments. His expertise lies in biotherapeutics, with a significant focus on Immuno-Oncology. Holding a PhD from the University of Liverpool, he is described by colleagues as dedicated, dynamic, and innovative.

He has successfully architected and led the worldwide translational strategy for at least 30 major drug development programs from early development through to late-stage trials.

Personality Overview

Dynamic But Sincere

Friendly But Fast

Driven But Considerate

If they are convinced, they can become very strong champions for your product  They have the unique ability to win both love and respect from their team (or outsiders) They combine a unique set of diverse traits where they are fast and friendly but can slow down to be thorough when needed

Topics They Care About

Clinical Program Strategy
His career focuses on architecting and accelerating clinical programs across CROs and Pharma, blending strategic vision with operational precision to deliver results.
Translational Research
A core part of his current role is ensuring that bioanalytical research findings are effectively and strategically applied in clinical settings.
Immuno-Oncology
He has deep experience managing numerous Immuno-Oncology and Immunotoxicology programs, showcasing a specialization in this complex therapeutic area.

Media Appearances

Andrew has no verified media appearances

Work History

4-2024
Chief Medical Officer & Strategic Bioanalytical and Translational Research Officer at GLSA | Global Life Sciences Alliance
1-2021 - 9-2023
Senior Director, Global Alliance Management at Precision Medicine Group
8-2017 - 12-2020
Director, Scientific Project Management and Client Services (Site head) at Intertek
8-2015 - 7-2017
Director of Immunobiology at ABL Inc.
4-2013 - 8-2015
Director, Research and Development at Nexelis

Education

PhD from University of Liverpool
Master’s Degree from The Manchester Metropolitan University

More Information

Social Presence :

Prographics :

Exp : 25 Location : Greater Seattle Area, United States Job Level : Leadership Designation : Chief Medical Officer & Strategic Bioanalytical and Translational Research Officer at GLSA | Global Life Sciences Alliance
URL has been copied!

Insights For Selling To Andrew

During A Call Or A Meeting

DO's

  • Showcase existing customers and use case-studies to grab their attention
  • Ask them for a lunch or coffee once some rapport has been established
  • Keep your pitch focused on the impact but nurture the relationship too

DONT's

  • Don’t be too verbose or overly friendly; a little bit, however, is fine
  • Avoid focusing only on the product or its ROI, keep building trust subtly
  • Don’t be very informal during the early interactions even if they are being so themselves

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Andrew is

  • Nothing less than a strong combination of proof of results, relationship and high levels of professionalism is effective with them.
  • Will you ever get a clear answer from Andrew

  • They can say no while staying friendly, but can also be pursuaded to reconsider

Insights For Deal Planning

    How fast (or slow) will Andrew move?

  • They are generally fast movers and can take quick decisions
  • Can Andrew take some risk or not?

  • They have high risk-appetite but can get ahead of themselves once in a while. Observe carefully

You And Andrew

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.